Navigation Links
Alexza to Announce 2011 Third Quarter Financial Results on Monday, November 7, 2011
Date:10/27/2011

re information about Alexza, the Staccato system technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

The anticipated news release and conference call will contain forward-looking statements that involve significant risks and uncertainties. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs, including the adequacy of the Company's capital to support the Company's operations, the potential of the Company's ADASUVE NDA resubmission to adequately address the issues in the Complete Response Letter, the timing of the FDA's review of the NDA, the eventual prospects that ADASUVE will be approved for marketing in the U.S., and the timing and prospects for regulatory approval to market ADASUVE in Europe, Latin America, Russia and the Commonwealth of Independent States countries. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2010, and the Company's other Periodic and Current Reports filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... BioCorRx, Inc. ( BICX ... is a healthcare solutions organization, which focuses solely on ... billion in the U.S. alone. The Company created a unique ... a specially compounded form for outpatient surgical implantation. The Company ... New Zealand ) to the specially formulated ...
(Date:3/27/2015)... March 27, 2015  The quality function within the ... products meet quality standards at every stage of the ... quality leaders also have the challenge of balancing quality ... Those who don,t effectively balance these priorities risk funding ... marketplace failure and regulatory scrutiny. For the ...
(Date:3/27/2015)... 27, 2015 Levi & Korsinsky announces it ... OHRP ) concerning possible violations of federal securities ... Company in connection with its study of the drug ... or contact Joseph E. Levi, Esq. ... telephone at (212) 363-7500, toll-free: (877) 363-5972. ...
Breaking Medicine Technology:Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S. 2New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2
... Prometheus Laboratories Inc., a,specialty pharmaceutical company, today ... Diagnostic, the first and only blood test,for ... measurable,differences in the expression of particular biomarkers ... The identification of these biomarkers,combined with a ...
... polyps that can be ... missed during colonoscopy, ... Annual Scientific Meeting in Orlando (ACG 2008), renowned,gastroenterologist Douglas K. ... the efficacy of the Third,Eye(R) Retroscope(R), a new device that ...
Cached Medicine Technology:Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5
(Date:3/29/2015)... Final Cut Pro X ... Film Studios, entitled TranSports. , “TranSports is a ... Cut Pro X,” said Christiana Austin, CEO of Pixel ... to effortlessly transition using this cool sports transition tool.” ... uniquely styled transition pack for Final Cut Pro X. ...
(Date:3/28/2015)... Coffee could not only perk you up in ... disease, researchers have found. , They found that those who ... antioxidants. Antioxidants fight gum disease. Does coffee, then, help fight ... Henry M. Goldman School of Dental Medicine explored in a ... the Journal of Periodontology. , “This is the first long-term ...
(Date:3/28/2015)... March 28, 2015 With more ... the fields of osteoporosis, osteoarthritis and musculoskeletal diseases ... it may be the first time in the ... forum that the hot-button topic is an emerging ... the well-accepted scientific principles of Wolff’s law, osteogenic ...
(Date:3/28/2015)... India Network visitor health insurance announced ... visitors who purchase the plan before arrival in the ... purchase the insurance program as soon as travel plans ... pre-existing medical conditions. Parents and grandparents traveling from India ... serious consequences to their health. Many visitors may not ...
(Date:3/28/2015)... 28, 2015 One in three young ... research presented today at the American Orthopaedic Society for ... examined the long term success of surgery for patients ... survey data from 242 patients who underwent ACL reconstruction ... Roe, MBBS, FRACS, from North Sydney Orthopaedic and Sports ...
Breaking Medicine News(10 mins):Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2
... a new study finds, , , THURSDAY, March 13 (HealthDay ... in children, especially the very youngest, new research contends. ... to 14 years old, showed that environmental tobacco exposure ... of vascular injury, suggesting an increased risk of heart ...
... with the Strategic Placement, of Banners during this ... this Year,s Field utilize SURGEX(TM) to Compliment Their ... Millennium,Biotechnologies Inc., wholly-owned subsidiary of Millennium Biotechnologies,Group, ... many PGA,players and spectators will be introduced to ...
... Va., March 13 An ALFA initiative,to eliminate the ... in,assisted living communities was filed today on Capitol Hill., ... (R-21st FL) and,twelve other House members are sponsoring HR ... Equity Act of 2008. This bipartisan,measure corrects an apparent ...
... new campaign is underway to help,raise awareness of ... of America, or ADAA, has launched the "Treat ... to educate Americans about,OCD symptoms and treatment options., ... Disorders Association of America,at: http://media.medialink.com/WebNR.aspx?story=34804 , ...
... SAUSALITO, Calif., March 13 Take Care Health ... clinics and a wholly-owned,subsidiary of Walgreens (NYSE, Nasdaq: ... & Partners (BSSP), a full-service marketing,communications firm headquartered ... of record., BSSP is tasked with developing ...
... Marathon Mark Leventhal, Esq.,Founder and President ... -- the first in the nation ... an attorney -- is featured on,the cover ... ("YL") in an article,entitled "Accessible Accountability: Attorney,s ...
Cached Medicine News:Health News:Secondhand Smoke Hikes Tots' Risk of Heart Disease 2Health News:Secondhand Smoke Hikes Tots' Risk of Heart Disease 3Health News:SURGEX(TM) Joins the Team of Sponsors for the PGA Tour's 2008 Arnold Palmer Invitational Presented by MasterCard 2Health News:SURGEX(TM) Joins the Team of Sponsors for the PGA Tour's 2008 Arnold Palmer Invitational Presented by MasterCard 3Health News:SURGEX(TM) Joins the Team of Sponsors for the PGA Tour's 2008 Arnold Palmer Invitational Presented by MasterCard 4Health News:ALFA Aims to Provide Relief to Seniors 2Health News:Take Care Health Systems Names Butler, Shine, Stern & Partners as First Marketing Agency of Record 2Health News:Take Care Health Systems Names Butler, Shine, Stern & Partners as First Marketing Agency of Record 3Health News:Leventhal Weight Loss President Featured on Cover of Young Lawyer 2
... is the highly concentrated multi-purpose detergent ... or with an ultrasonic cleaner. ... blood and organic material and safe ... to clean surgical instruments manually or ...
... need for critical patients more waveforms, ... comprehensive calculations package and cardiac output ... can transport with your patients., We ... functions which means less time ...
The ApexPro CH is operational within the WMTS. It offers operating performance, up to 240 WMTS channels, and up to 120 hours of battery life....
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
Medicine Products: